Preview

Diabetes mellitus

Advanced search

A clinical case of exocrine pancreatic insufficiency in a patient with type 1 diabetes mellitus

https://doi.org/10.14341/DM12884

Abstract

The pancreas belongs to the glands of mixed secretion and simultaneously performs both endo- and exocrine functions. Exocrine pancreatic insufficiency (EPI) is the general name for the malabsorption process caused by inadequate production and decreased activation of the enzymes of the pancreas acinar cells, such as amylase, lipase and protease, which are necessary for digestion. The prevalence of EPI in patients with type 1 diabetes, according to many authors, varies from 25 to 59%, which is determine by the data of pancreatic elastase-1. In this work, we present a clinical case of confirmed exocrine pancreatic insufficiency in a patient with a 6-year history of type 1 diabetes, which became the main cause of the development of episodes of hypoglycemia after meals. In the course of further studies, antibodies to lactoferrin and a reduced prostate volume, determined by MRI data, high levels of antibodies to glutamate decarboxylase and zinc co-transporter 8, as well as residual insulin secretion based on the level of C-peptide on an empty stomach detected.

About the Authors

M. R. Ragimov
Endocrinology Research Centre
Russian Federation

Magomedkerim R. Ragimov - MD, PhD student

11 Dm. Ulyanova street, 117036 Moscow


Competing Interests:

none



T. V. Nikonova
Endocrinology Research Centre
Russian Federation

Tatiana V. Nikonova - MD, PhD; Scopus Author ID: 55553886600.

Moscow


Competing Interests:

none



E. V. Marchenko
Endocrinology Research Centre
Russian Federation

Elena V. Marchenko - MD.

Moscow


Competing Interests:

none



N. M. Malysheva
Endocrinology Research Centre
Russian Federation

Natalia M. Malysheva - PhD in Biology; Scopus Author ID: 57197834989.

Moscow


Competing Interests:

none



O. S. Derevyanko
Endocrinology Research Centre
Russian Federation

Olga S. Derevyanko - MD, PhD; Scopus Author ID: 56095072000.

Moscow


Competing Interests:

none



References

1. DiMagno EP, Malagelada JR, Go VL, et al. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977;296(23):1318-1322. doi: https://doi.org/10.1056/NEJM197706092962304

2. Radlinger B, Ramoser G, Kaser S. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes. Curr Diab Rep. 2020;20(6):18. doi: https://doi.org/10.1007/s11892-020-01304-0

3. Hayden MR, Patel K, Habibi J, et al. Attenuation of Endocrine-Exocrine Pancreatic Communication in Type 2 Diabetes: Pancreatic Extracellular Matrix Ultrastructural Abnormalities. J Cardiometab Syndr. 2008;3(4):234-243. doi: https://doi.org/10.1111/j.1559-4572.2008.00024.x

4. Piciucchi M, Capurso G, Archibugi L, et al. Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol. 2015;2015:1-7. doi: https://doi.org/10.1155/2015/595649

5. Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;(68):18-22. doi: https://doi.org/10.1016/j.ejim.2019.07.021

6. Tod J, Fine D. Fecal elastase: a useful test for pancreatic insufficiency? Dig Dis Sci. 2010;55(10):2709-2711. doi: https://doi.org/10.1007/s10620-010-1409-9

7. Forsmark CE. Diagnosis and Management of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2018;16(3):306-315. doi: https://doi.org/10.1007/s11938-018-0186-y

8. Virostko J, Williams J, Hilmes M, et al. Pancreas volume declines during the first year after diagnosis of type 1 diabetes and exhibits altered diffusion at disease onset. Diabetes Care. 2019;42(2):248-257. doi: https://doi.org/10.2337/dc18-1507

9. Virostko J, Hilmes M, Eitel K, et al. Use of the electronic medical record to assess pancreas size in type 1 diabetes. PLoS One. 2016;11(7):e0158825. doi: https://doi.org/10.1371/journal.pone.0158825

10. Ragimov MR, Nikonova TV, Babaeva DM, et al. Structurall features of the pancreas in patients with type 1 diabetes mellitus. Diabetes Mellitus. 2022;25(3):239-248. (In Russ.) doi: https://doi.org/10.14341/DM12892

11. DeSouza SV, Singh RG, Yoon HD, et al. Pancreas volume in health and disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(8):757-766. doi: https://doi.org/10.1080/17474124.2018.1496015

12. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut. 1981;22(2):158-167. doi: https://doi.org/10.1136/gut.22.2.158

13. Hardt PD, Ewald N, Bröckling K, et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and non-alcoholic chronic pancreatitis. JOP. 2008;9(6):683-689.

14. Cesare E, Previti M, Lombardo F, et al. Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes. Ann N Y Acad Sci. 2004;1037(1):131-132. doi: https://doi.org/10.1196/annals.1337.021

15. Pirart J. Diabetes Mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1(4):252-263. doi: https://doi.org/10.2337/diacare.1.4.252

16. Hardt PD, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res. 2011;2011:1-7. doi: https://doi.org/10.1155/2011/761950

17. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933-942. doi: https://doi.org/10.1002/ca.20543

18. Djuric-Stefanovic A, Masulovic D, Kostic J, et al. CT volumetry of normal pancreas: correlation with the pancreatic diameters measurable by the cross-sectional imaging, and relationship with the gender, age, and body constitution. Surg Radiol Anat. 2012;34(9):811-817. doi: https://doi.org/10.1007/s00276-012-0962-7

19. Wathle GK, Tjora E, Ersland L, et al. Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls. J Magn Reson Imaging. 2014;39(2):448-454. doi: https://doi.org/10.1002/jmri.24167

20. Kunovský L, Dítě P, Jabandžiev P, et al. Causes of exocrine pancreatic insufficiency other than chronic pancreatitis. J Clin Med. 2021;10(24):5779. doi: https://doi.org/10.3390/jcm10245779


Supplementary files

Review

For citations:


Ragimov M.R., Nikonova T.V., Marchenko E.V., Malysheva N.M., Derevyanko O.S. A clinical case of exocrine pancreatic insufficiency in a patient with type 1 diabetes mellitus. Diabetes mellitus. 2023;26(1):93-97. (In Russ.) https://doi.org/10.14341/DM12884

Views: 4893


ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)